ARCHIVES

DCBD Board Approves Concept for Astrocytoma Molecular Probes

This article is from The Cancer Letter archive.

Vol. 14 No. 30 | July 22, 1988

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Amgen names PhRMA executive Rodger Currie vice president for government affairs.

April 30, 2004

FDA Approves Erbitux for Head & Neck Cancer.

March 3, 2006

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

Patients urge Medicare to allow an open formulary for cancer treatment.

October 15, 2004

In Brief: Weissman Heads DCBD Board; Extra Money For Grants Lifts Funding Level To 35%

October 14, 1977